Teva faces lawsuit from Israel over unpaid Copaxone royalties

Teva's Copaxone is at the center of a $100M lawsuit from the state of Israel over alleged unpaid royalties.

Related Keywords

,Teva Pharmaceutical Industries ,Copaxone ,Lawsuit ,Multiple Sclerosis ,Weizmann Institute Of Science ,Israel ,Fierce Pharma Homepage ,Pharma ,